Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» neurodegenerative disease
neurodegenerative disease
Sangamo secures $50M upfront in neurodegenerative pact with Roche's Genentech
Fierce Biotech
Tue, 08/6/24 - 11:34 am
Sangamo Therapeutics
Roche
Genentech
neurodegenerative disease
Bristol Myers Squibb checks 'yes' on another Prothena neurodegenerative therapy
Fierce Biotech
Wed, 05/29/24 - 09:30 pm
Bristol Myers Squibb
Prothena
neurodegenerative disease
PRX019
6 Neuro Data Readouts to Watch in the First Half of 2024
BioSpace
Mon, 01/22/24 - 11:53 am
neurodegenerative disease
clinical trials
ALS
major depressive disorder
Huntington's disease
Sanofi
Denali Therapeutics
Intra-Cellular Therapies
lumateperone
Annexon Biosciences
Guillain-Barré Syndrome
ANX005
Wave Life Sciences
Praxis Precision Medicines
Merck Drops Up to $610M on Neuro Disease-Focused Caraway Therapeutics
BioSpace
Tue, 11/21/23 - 12:05 pm
Merck
M&A
neurodegenerative disease
Caraway Therapeutics
Companies to Watch: 12 Late-Stage Contenders in Neurodegenerative Disease
BioSpace
Mon, 07/24/23 - 09:57 am
neurodegenerative disease
Alzheimer's disease
Axsome Therapeutics
Eli Lilly
Anavex
TauRx
AB Science
ALS
BrainStorm Cell Therapeutics
Seelos Therapeutics
Parkinson's Disease
AbbVie
Mitsubishi Tanabe Pharma
Annovis
Huntington's disease
Prilenia Therapeutics
Neurocrine
BMS makes quickfire bets on neurodegeneration, paying $95M to exercise Evotec, Prothena options
Fierce Biotech
Tue, 07/11/23 - 10:13 am
Bristol Myers Squibb
neurodegenerative disease
Prothena
Alzheimer's disease
Evotec
BMS re-ups 'highly productive' legacy neurodegeneration partnership with Evotec for $50M upfront
Fierce Biotech
Tue, 03/28/23 - 10:44 pm
Bristol Myers Squibb
Celgene
Evotec
neurodegenerative disease
Biogen, BioAge and PTC Present Novel MoAs in Neurodegenerative Diseases
BioSpace
Mon, 11/7/22 - 10:52 am
neurodegenerative disease
Biogen
BioAge Labs
PTC Therapeutics
Brain disease startup Neumora draws more funding for ambitious research plan
BioPharma Dive
Tue, 10/11/22 - 10:22 am
Neumora
neurodegenerative disease
psychiatric disease
funding
A startup led by Novartis veteran raises $80M to develop gene therapies for the brain
BioPharma Dive
Thu, 12/2/21 - 12:15 pm
AviadoBio
gene therapy
Novartis
Lisa Deschamps
neurodegenerative disease
Origami Therapeutics developing treatments for neurodegenerative diseases with ML and computational chemistry
MedCity News
Thu, 11/4/21 - 10:26 am
Origami Therapeutics
protein degradation
neurodegenerative disease
Huntington's disease
Teva, Modag to develop drug candidates for neurodegenerative disease
Pharmaceutical Business Review
Wed, 10/27/21 - 11:04 am
Teva Pharmaceutical
Modag
drug development
neurodegenerative disease
Spurred on by OrbiMed partner's diagnosis, Vanqua Bio takes aim at neurodegenerative disease with blue-chip backers
Endpoints
Tue, 09/14/21 - 10:53 am
Vanqua Bio
OrbiMed
neurodegenerative disease
funding
Bristol Myers greenlights neurodegenerative medicine from Evotec pact for $20M
Fierce Biotech
Fri, 09/3/21 - 11:22 am
Evotec
Bristol-Myers Squibb
EVT8683
neurodegenerative disease
Ipsen forges $1bn alliance with Exicure on neurodegenerative diseases
Pharmaforum
Mon, 08/2/21 - 10:54 am
Ipsen
Exicure
neurodegenerative disease
PAQ Therapeutics scores $30M to unleash “Pac-Man” drugs on neuro disease
MedCity News
Fri, 07/16/21 - 10:36 am
PAQ Therapeutics
funding
neurodegenerative disease
targeted protein degradation
Muna raises $73M to go after Alzheimer's, Parkinson's and MS
Fierce Biotech
Fri, 07/9/21 - 09:52 am
Muna Therapeutics
small molecule drugs
neurodegenerative disease
funding
Aduhelm’s accelerated approval offers a promising roadmap for rare neurological diseases
Stat
Wed, 07/7/21 - 10:36 pm
FDA
Biogen
Aduhelm
accelerated approvals
neurodegenerative disease
GSK, under pressure to perform, pens $2.2B deal with Alector focused on neuro R&D, Alzheimer's
Fierce Biotech
Fri, 07/2/21 - 11:00 am
GSK
biobucks
Alector
neurodegenerative disease
Alzheimer's disease
Drugmakers suggest tweaks to FDA’s neurodegenerative disease gene therapy guidance
RAPS.org
Wed, 04/7/21 - 10:20 am
regulatory
FDA
Health Canada
neurodegenerative disease
Pages
1
2
next ›
last »